441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
作者： A. Dowlati , M.A. Huseni , S. Gettinger , V.M. Villaflor , B. Besse
DOI: 10.1016/S0923-7534(21)00599-8
关键词:
摘要:
oup.com
sci-hub.st 参考文章(0)
作者： A. Dowlati , M.A. Huseni , S. Gettinger , V.M. Villaflor , B. Besse
DOI: 10.1016/S0923-7534(21)00599-8
关键词:
摘要: